Ubiquitin Associated and SH3 Domain Containing, A (UBASH3A) Peptide
-
- Target See all UBASH3A products
- UBASH3A (Ubiquitin Associated and SH3 Domain Containing, A (UBASH3A))
- Origin
- Human
-
Source
- Synthetic
- Application
- Blocking Peptide (BP), Western Blotting (WB)
- Characteristics
- This is a synthetic peptide designed for use in combination with anti-UBASH3A antibody (Catalog #: ARP45769_P050). It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications.
- Purification
- Purified
-
-
- Application Notes
- Each Investigator should determine their own optimal working dilution for specific applications.
- Restrictions
- For Research Use only
-
- Format
- Lyophilized
- Reconstitution
- Add 100 μL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.
- Concentration
- 1 mg/mL
- Buffer
- Final peptide concentration is 1 mg/mL in PBS.
- Handling Advice
- Avoid repeated freeze-thaw cycles.
- Storage
- -20 °C
- Storage Comment
- For longer periods of storage, store at -20°C. Avoid repeat freeze-thaw cycles.
-
- Target
- UBASH3A (Ubiquitin Associated and SH3 Domain Containing, A (UBASH3A))
- Background
-
UBASH3A interferes with CBL-mediated down-regulation and degradation of receptor-type tyrosine kinases. It also promotes accumulation of activated target receptors, such as T-cell receptors, EGFR and PDGFRB, on the cell surface.
Alias Symbols: CLIP4, STS-2, TULA, TULA-1
Protein Interaction Partner: UBB,ALK,DNM1,UBE2L3
Protein Size: 661 - Molecular Weight
- 74 kDa
- Gene ID
- 53347
- NCBI Accession
- NM_018961, NP_061834
- UniProt
- P57075
-